USPTO serial 79294494
HUTRIGEL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 17, 2021
- Examiner
- BIFTU, BENIAM
- Law office
- TMO LAW OFFICE 117
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with HUTRIGEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cell growth media for growing cells for use in scientific and research use; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes other than for medical or veterinary use; biological preparations for use in biotechnological product development other than medical or veterinary use; biochemicals for in vitro and in vivo scientific use; reagents for research purposes; reagents for medical research; collagen used as a raw ingredient in the manufacture of cosmetics; collagen peptides for cosmetics; collagen for use as a raw ingredient in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; cells for scientific or laboratory purposes; biological preparations for scientific purposes, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological material, namely, cell culture media for scientific and research use *, not for medical or veterinary purposes * ; Biological preparations, namely, extracellular matrix for cell cultures for use in scientific research *, not for medical or veterinary purposes * ; biological preparation, namely, type 4 collagen and laminin for bioprinting for industrial use *, not for medical or veterinary purposes * ; biological material for bioprinting, namely, type 4 collagen and laminin *, not for medical or veterinary purposes * | ACTIVE | — |
| 005 | Pharmaceutical preparations for skin care; drug delivery agents in the form of solution, gel, and powder that facilitate the delivery of pharmaceutical preparations; medicament formulating agents for promoting wound healing of damaged epithelial tissues, connective tissues, nervous tissues, or dental tissues; biological preparations for medical or veterinary purposes, namely, for the treatment of traumatic wound, burn, ulcer, corneal diseases, mucosal and submucosal injuries, nerve injuries, internal organ injuries, tendon and ligament injuries, or dental diseases; culture media for medical use; biotechnological preparations for medical purposes, namely, biotechnologically-formed proteins for the treatment of traumatic wound, burn, ulcer, corneal diseases, mucosal and submucosal injuries, nerve injuries, internal organ injuries, tendon and ligament injuries, or dental diseases; cellular function activating agents for medical purposes; Medicated skin care preparations for medical purposes; collagen for medical purposes; pharmaceutical compositions, namely, pharmaceutical preparations for promoting wound healing of damaged epithelial tissues, connective tissues, nervous tissues, or dental tissues; surgical implants comprised of living tissues; Natural biomaterials for tissue restoration for medical purposes; implants comprising living tissue for guided tissue regeneration; implantable materials comprising living tissue for use in guided tissue regeneration; surgical implants comprising living tissues, namely, stem cells; extracellular matrix, namely, type 4 collagen, and laminin for medical purposes; Bone void fillers consisting of biological materials for medical purposes; biological preparations for medical purposes, namely, for the treatment of traumatic wound, burn, ulcer, corneal diseases, mucosal and submucosal injuries, nerve injuries, internal organ injuries, tendon and ligament injuries, or dental diseases; biological tissue cultures for medical purposes; biological tissue culture media for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 18, 2022 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jun 18, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 31, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 31, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 17, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 21, 2021 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Oct 18, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 18, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Oct 18, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 19, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 17, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 1, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 1, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 12, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 23, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 23, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 23, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 23, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 20, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 20, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 20, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 20, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 6, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |